A Texas judge refused to grant Lance Armstrong's request to dismiss a $3 million lawsuit filed by Acceptance Insurance Holdings to recover bonuses in light of the cyclist's admission of doping. The company's attorney stated that he will move to question the cyclist under oath.
Acceptance held a contract with Armstrong to pay bonuses for winning the Tour de France and other races. After Armstrong admitted using performance-enhancing drugs, the company filed a $3 million lawsuit against the cyclist to recover the bonuses from the years 1999 to 2001.
Armstrong argued to dismiss the case, claiming that the statute of limitations of fraud or breach of contract claims expired in 2011.
The company argues that the clock did not start until Armstrong admitted he used performance-enhancing drugs to win the Tour de France every year from 1999 to 2005.
With Armstrong's request denied and the trial proceeding, attorney for Acceptance Insurance Holdings Mark Kincaid said that the company will seek to question witnesses, including Armstrong, who has been reluctant to go under oath in other pending cases.
Since Armstrong admitted to doping in January, several organizations including Armstrong's primary sponsor, the U.S. Postal Service, have sued the cyclist, seeking million of dollars of repayment.
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
